Fleming Fund partners with Pakistan to tackle the threat of antimicrobial resistance


The UK has expanded its partnership with Pakistan to tackle the growing threat of antimicrobial resistance (AMR) in the country.

The Fleming Fund is delighted to announce that it will invest more than £2.7 million in Pakistan to strengthen one-health AMR surveillance systems, improve laboratory infrastructure and build expertise by offering six professional fellowships to senior scientists.

Development Alternatives Incorporation (DAI) has been appointed as the lead grantee to deliver the Country Grant in Pakistan. The grant will support the generation of comprehensive data on AMR and will be delivered through the consortium including the Liverpool School of Tropical Medicine, Aga Khan University, and Health Security Partners.

DAI's work will be complemented by six professional fellowships offering tailored professional development to senior scientists who are engaged in AMR surveillance in Pakistan.

Today’s announcement is further evidence that the UK is committed to working with Pakistan to help tackle global issues. Anti-microbial resistance is a threat which is killing hundreds of thousands of people across the world each year. The country grant will help support the technical development of the health infrastructure in Pakistan, drive innovation, and build greater scientific links between our two great nations; it will, potentially, save lives.

Thomas Drew CMG, the British High Commissioner to Pakistan

We’re very pleased to collaborate closely with UK Government through Fleming Fund grant for supporting us in our efforts to prevent antimicrobial resistance in Pakistan; we see them as a key partner in providing critical technical and laboratory strengthening support.

Maj. Gen. Aamer Ikram SI (M), Executive Director of National Institute of Health

It has been a pleasure to work in partnership with the Government of Pakistan and the UK government to help strengthen Pakistan’s health systems and contribute to tackling the threat of antimicrobial resistance. With support through our partners, we hope this will eventually support the Government of Pakistan to improve its understanding of the AMR problem and to prepare appropriate strategies to tackle it.

Jawaad Vohra, International Development Pakistan, Country Grant Representative for Management Agent, Mott MacDonald

More Like This

Inauguration of upgraded national laboratories, supported by the Fleming Fund, UK Health Security Agency and DAI.

The President reiterated his support for the Fleming Fund’s activities in Pakistan during a meeting with the British High Commissioner for Pakistan, Dr Christian Turner.